Initial Guidance Regarding the Inflation Reduction Act Medicare Prescription Drug Inflation Rebate Program

The Inflation Reduction Act of 2022 establishes the Medicare Prescription Drug Inflation Rebate Program, which requires drug companies to pay rebates, referred to as inflation rebates, to Medicare if they raise their prices for certain Medicare Part B and Medicare Part D drugs faster than the rate of inflation.